Feed ROMA
Summary
18 / 100 · Bulios Score
Valuation 0Growth 0Profitability 4Quality 2Debt 100Stability 15
What speaks for it
- It has no debt and holds $6.90M in cash.
What to watch
- The company made a loss over the last 12 months.
- Revenue fell by 11% a year over the last 3 years.
- It passes only 1 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveThe company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
It is shrinkingRevenue (HKD)
20222023202420252026
Diluted EPS (HKD)
20222023202420252026
Revenue fell by 7.0% a year over 5 years. Over the last 3 years it fell by 11% a year.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $26.8M.
Profitability in detailIs it financially healthy?
YesCash and short-term investments $6.90M
Debt $0.00
Free cash flow over 12 months -$19.5M
It has no debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 1
- Hold 0
- Sell 0
No analyst has published a price target.
100% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2026By product
The company reports no revenue by product.
By region
- HONG KONG 82%
- SINGAPORE 18%
HONG KONG brings in 82% of revenue.
Segments in detail